UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 552

Sortiert nach

Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Leukemia, 2009-08, Vol.23 (8), p.1528-1534

2009

Volltextzugriff (PDF)

Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.949-954

2016

Volltextzugriff (PDF)

Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trial

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.616-621

2014

Volltextzugriff (PDF)

Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older

Bone marrow transplantation (Basingstoke), 2018-06, Vol.53 (6), p.756-763

2018

Volltextzugriff (PDF)

Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis

Journal of neurology, neurosurgery and psychiatry, 2007-07, Vol.78 (7), p.771-771

2007

Volltextzugriff (PDF)

A unique schedule of palonosetron, ondansetron, and dexamethasone for the prevention of delayed nausea and vomiting in patients receiving myeloablative chemotherapy

Journal of oncology pharmacy practice, 2019-09, Vol.25 (6), p.1336-1342

2019

Volltextzugriff (PDF)

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

The New England journal of medicine, 2017-03, Vol.376 (10), p.917-927

2017

Volltextzugriff (PDF)

Preferential depletion of host over donor T cells through in vivo decay of active rabbit-anti-thymocyte globulin levels during reduced intensity conditioning

Bone marrow transplantation (Basingstoke), 2015-06, Vol.50 (6), p.829-833

2015

Volltextzugriff (PDF)

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.468-475

2010

Volltextzugriff (PDF)

UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL

Hematological oncology, 2017-06, Vol.35 (S2), p.54-55

2017

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (6), p.537-545

2008

Volltextzugriff (PDF)

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

Blood, 2008-04, Vol.111 (8), p.4022-4028

2008

Volltextzugriff (PDF)

High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (7), p.581-587

2004

Volltextzugriff (PDF)

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4754-4759

2009

Volltextzugriff (PDF)

Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia, 2020-12, Vol.34 (12), p.3338-3347

2020

Volltextzugriff (PDF)

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

Bone marrow transplantation (Basingstoke), 2001-02, Vol.27 (4), p.387-396

2001

Volltextzugriff (PDF)

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

The Lancet. Haematology, 2017-09, Vol.4 (9), p.e431-e442

2017

Volltextzugriff (PDF)

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

Haematologica (Roma), 2020-01, Vol.105 (1), p.47

2020

Volltextzugriff (PDF)

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Volltextzugriff (PDF)

FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

Bone marrow transplantation (Basingstoke), 2003-09, Vol.32 (6), p.581-585

2003

Volltextzugriff (PDF)

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

Blood, 2003-11, Vol.102 (10), p.3521-3529

2003

Volltextzugriff (PDF)

1 – 25 von 552

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(435)
Mit Volltextzugriff
(501)

Publikationsform

Sprache

Englisch
(549)
Japanisch
(59)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(249)
Life Sciences & Biomedicine
(247)
Humans
(177)
Hematology
(131)
Male
(122)
Adult
(109)
Female
(109)
Middle Aged
(107)
Transplantation
(95)
Aged
(82)
Immunology
(76)
Biological And Medical Sciences
(71)
Animals
(69)
Medical Sciences
(54)
Oncology
(52)
Hematology, Oncology And Palliative Medicine
(49)
Hematopoietic Stem Cell Transplantation - Methods
(41)
Hematopoietic Stem Cell Transplantation
(38)
Retrospective Studies
(38)
Transplantation, Homologous
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic cell transplantation

Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-cell chimerism results in favorable outcomes for high-risk older recipients of alemtuzumab-containing reduced-intensity unrelated donor allogeneic transplant: a prospective phase II trial

Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older

Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis

A unique schedule of palonosetron, ondansetron, and dexamethasone for the prevention of delayed nausea and vomiting in patients receiving myeloablative chemotherapy

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Preferential depletion of host over donor T cells through in vivo decay of active rabbit-anti-thymocyte globulin levels during reduced intensity conditioning

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM

UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and haploidentical stem cell transplantation

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

Suchergebnisse filtern